Study at a glance
How was active vitamin D tested in human immune cells?
Researchers treated selected human immune cells called T cells with calcitriol, the active form of vitamin D, in the laboratory. They tested responses both with and without inflammatory signalling substances. They then examined how the treated cells affected other immune cells.
How did active vitamin D affect signals that activate immune cells?
Treated cells produced more CTLA-4, a molecule involved in limiting immune activation. They also removed more CD86, a molecule that helps other cells stimulate T cells. Blocking CTLA-4 supported its involvement in this process. Another immune-cell group, called dendritic cells, lost some stimulating molecules after contact with the treated T cells and became less effective at activating further T cells.
Did every immune response decrease?
No. Several inflammatory substances decreased, but IL-10, another signalling substance, changed in different directions under different conditions. Other markers linked with immune control did not all change clearly. Separate work on other immune-cell types found that some signals increased rather than decreased. A result in one cell type cannot therefore be treated as a result for the whole immune system.
Do these cell findings show that supplements improve immune health?
The study supports a specific way active vitamin D can help limit immune-cell activation. It tested cell behaviour as well as markers on cells. However, donor samples were small, and the experiments did not show improved disease symptoms, fewer infections or lasting immune benefits in people. They do not establish that supplements reproduce the result, or identify a supplement dose or target blood level.
Read the full article below ↓Active vitamin D supported a measurable immune-restraint mechanism in experiments with human T cells. Jeffery and colleagues found increased CTLA-4 expression, greater removal of costimulatory molecules from other cells and reduced subsequent responder activation. These are functional laboratory findings, not evidence that supplementation treats immune overactivation in patients. Read the companion Vitamin D, CTLA-4 and Immune Restraint: Full Study.
What did the researchers do?
The team activated selected human CD4 T cells and exposed them to calcitriol, including in inflammatory cytokine environments. They measured cytokines and regulatory markers, then tested interactions with cells displaying CD86 and with dendritic cells. The laboratory concentration is not a supplement-dose recommendation.
The experiments address a specific mechanism relevant to Vitamin D and Immune Overactivation. They did not measure disease symptoms, infection outcomes or long-term immune competence in a clinical trial.
What is the strongest finding?
The study moved beyond showing more CTLA-4 on a cell. Treated T cells acquired more CD86 from other cells through a process called transendocytosis. Blocking CTLA-4 helped test the pathway’s involvement. Dendritic cells exposed to the treated T cells had less CD80 and CD86 and were less effective at stimulating responder cells in the assay.
This provides functional support for one route of immune restraint. It is relevant to Vitamin D and Immune Tolerance, but it does not establish durable antigen-specific tolerance or remission of an autoimmune disease. The donor samples were small and differed among experiments.
Cytokine changes depended on context
Several inflammatory T-cell outputs, including IL-17, interferon-γ and IL-21, were reduced in studied conditions. IL-10 did not simply rise everywhere: its direction differed with the cytokine environment. Foxp3 and IL-2 also did not show a clear overall calcitriol effect in the reported analyses.
The lesson for Vitamin D and Cytokine Balance is that a regulatory function cannot be judged from one supposedly anti-inflammatory marker. The surrounding signals and the actual functional test matter.
Why this is not universal immune suppression
Kundu and colleagues’ experiments in other immune-cell populations found different directions of signalling response. Some dendritic-cell responses were attenuated, whereas primary monocyte responses could increase. These findings qualify the breadth of the interpretation without contradicting the specific T-cell mechanism.
Vitamin D and Immune Modulation therefore describes the evidence more accurately than a claim that vitamin D switches the immune system off. The studies tested different cells and functions, and neither establishes that a blood vitamin D concentration predicts the same response in every tissue.
The demonstrated cellular mechanism does not establish a sustained reduction in chronic inflammation, the broader topic discussed in Vitamin D and Chronic Inflammation. Vitamin D and Inflammatory Signalling helps distinguish the monocyte pathway measurements from the T-cell functional assay, while Vitamin D Signalling Pathways provides background on receptor-related responsiveness. These connections explain the physiology without supplying the missing clinical supplementation evidence.
Conclusion
The evidence supports a CTLA-4-linked restraint mechanism in cultured human cells, including under inflammatory cytokine conditions. It does not establish a clinical treatment effect, a target blood concentration or a supplementation regimen. Its main contribution is a functional mechanism with clearly defined limits.
This page is an original Vitamin D3 For Life explanation and critical appraisal of the research cited below.
Primary source and publication details
Related reading
Cell‐type‐specific modulation of innate immune signalling by vitamin D in human mononuclear phagocytes
Vitamin D is widely reported to inhibit innate immune signalling and dendritic cell (DC) maturation as a potential immunoregulatory mechanism.
Original paper ↗Read more →Vitamin D Antagonises the Suppressive Effect of Inflammatory Cytokines on CTLA-4 Expression and Regulatory Function
Therefore, in this study we have examined the effects of Th17 polarising conditions on CTLA-4 expression and function in human T cells and show that Th17 conditions can suppress the expression of CTLA-4 and its transendocytic function.
Original paper ↗Read more →Germanane Quantum Dots Promote Metabolic Reprogramming of Immune Cells Toward Regulatory T Cells and Suppress Inflammation In Vitro and In Vivo
Recently, nanomaterials have emerged as a tool in developing novel therapies against inflammatory diseases.
Original paper ↗Read more →Anti-Inflammatory Effects of Vitamin D on Human Immune Cells in the Context of Bacterial Infection
Vitamin D induces a diverse range of biological effects, including important functions in bone health, calcium homeostasis and, more recently, on immune function.
Original paper ↗Read more →Vitamin D and Inflammatory Signalling Across Cell Types: Full Evidence Review
Review of vitamin D effects on NF-κB, cytokines and immune-cell responses, including opposing findings and limits of translation to human health.
Read more →Vitamin D and Inflammatory Signalling Across Cell Types: Study Summary
A concise account of vitamin D signalling studies: differing cell responses, cytokine changes and the limits of claims about systemic inflammation.
Read more →Vitamin D and Immune Tolerance
Immune tolerance is the ability of the immune system to avoid inappropriate reactions against self and harmless exposures.
Read more →An Injectable Hydrogel Platform for Sustained Delivery of Anti-inflammatory Nanocarriers and Induction of Regulatory T Cells in Atherosclerosis
Cardiovascular immunotherapy has therefore become a recent focus for treatment, with the objective to develop approaches that can suppress excessive inflammatory responses by modulating specific immune cell populations.
Original paper ↗Read more →Keratinocyte-derived cytokine TSLP promotes growth and metastasis of melanoma by regulating the tumor-associated immune microenvironment
Malignant melanoma is a major public health issue displaying frequent resistance to targeted therapy and immunotherapy.
Original paper ↗Read more →Anti-Inflammatory Effects of 1,25(OH)2D/Calcitriol in T Cell Immunity: Does Sex Make a Difference?
Hence, the aim of this study was to investigate whether calcitriol could act differently in modulating T cell immunity of age-matched male and female healthy donors.
Original paper ↗Read more →Calcitriol inhibits osteoclastogenesis in an inflammatory environment by changing the proportion and function of T helper cell subsets (Th2/Th17)
Finally, the effects of calcitriol on antigen presentation by DCs during these cellular events were evaluated.
Original paper ↗Read more →Calcitriol modifies tight junctions, improves barrier function, and reduces TNF‐α‐induced barrier leak in the human lung‐derived epithelial cell culture model, 16HBE 14o‐
Both effects were concentration dependent and active out to 168 h post‐treatment.
Original paper ↗Read more →Calcitriol promotes M2 polarization of tumor-associated macrophages in 4T1 mouse mammary gland cancer via the induction of proinflammatory cytokines
Our research found that vitamin D3 (VD3) treatment increased lung metastasis in mice with 4T1 murine breast cancer (BC).
Original paper ↗Read more →Calcitriol Reduces the Inflammation, Endothelial Damage and Oxidative Stress in AKI Caused by Cisplatin
Cisplatin treatment is one of the most commonly used treatments for patients with cancer.
Original paper ↗Read more →Capric Acid Behaves Agonistic Effect on Calcitriol to Control Inflammatory Mediators in Colon Cancer Cells
This study aimed to assess the sensitivity of calcitriol alone and combined with capric acid, and identify the possible influence of calcitriol on inflammatory mediators.
Original paper ↗Read more →Effects of calcitriol (1, 25-dihydroxy-vitamin D3) on the inflammatory response induced by H9N2 influenza virus infection in human lung A549 epithelial cells and in mice
Culture supernatants were collected every 24 h post infection and the viral growth kinetics and inflammatory response were evaluated.
Original paper ↗Read more →Effects of calcitriol on oxidative burst, phagocytic function, and leukocyte cytokine production in shelter dogs
The active metabolite of vitamin D, calcitriol, has been shown across many different species to augment innate immune responses and dampen aberrant proinflammatory cytokine production.
Original paper ↗Read more →Low-dose oral cholecalciferol is associated with higher numbers of Helios+ and total Tregs than oral calcitriol in renal allograft recipients: an observational study
We evaluated whether there was a difference in the absolute numbers of Helios+, Helios−, CTLA-4+, IFNg+, and total Tregs among the patient groups.
Original paper ↗Read more →Maternal vitamin D deficiency impairs Treg and Breg responses in offspring mice and deteriorates allergic airway inflammation
This study aimed at investigating the effects of maternal VitD-deficiency during pregnancy on Treg and Breg responses in offspring mice with house dust mite (HDM)-induced allergic airway inflammation.
Original paper ↗Read more →Modulation of renal inflammation and tubular injury by calcitriol in patients with early diabetic kidney disease: a randomized controlled trial
This double-blind, randomized controlled trial investigated the effects of calcitriol supplementation on kidney injury biomarkers in patients with early DKD.
Original paper ↗Read more →The Potential Effect of Intravenous Calcitriol on the Ischemia-Reperfusion Process and Inflammatory Biomarkers in Patients Following Percutaneous Coronary Intervention (PCI)
This study aimed to investigate the efficacy of calcitriol on Ischemia-reperfusion Injury (IRI) and inflammatory biomarkers in patients with non-ST-segment elevation acute coronary syndromes (NSTEACS) undergoing elective Percutaneous Coronary Intervention (PCI).
Original paper ↗Read more →Original sources
Vitamin D Antagonises the Suppressive Effect of Inflammatory Cytokines on CTLA-4 Expression and Regulatory Function
Therefore, in this study we have examined the effects of Th17 polarising conditions on CTLA-4 expression and function in human T cells and show that Th17 conditions can suppress the expression of CTLA-4 and its transendocytic function.
Publication details
Vitamin D Antagonises the Suppressive Effect of Inflammatory Cytokines on CTLA-4 Expression and Regulatory Function. Louisa E. Jeffery, Omar S. Qureshi, David Gardner, Tie Z. Hou, Zoe Briggs, Blagoje Soskic, Jennifer Baker, Karim Raza, David M. Sansom. PLoS ONE; 2015; 10; 7; e 0131539. DOI: 10.1371/journal.pone.0131539. CC BY. This page provides an original explanatory appraisal; no source figures are reproduced.
Cell‐type‐specific modulation of innate immune signalling by vitamin D in human mononuclear phagocytes
Vitamin D is widely reported to inhibit innate immune signalling and dendritic cell (DC) maturation as a potential immunoregulatory mechanism.
Publication details
Cell‐type‐specific modulation of innate immune signalling by vitamin D in human mononuclear phagocytes. Rhiannon Kundu, Aikaterini Theodoraki, Carolin T Haas, Yanjing Zhang, Benjamin Chain, Janos Kriston‐Vizi, Mahdad Noursadeghi, Bernard Khoo. Immunology; 2017; 150; 1; 55 to 63. DOI: 10.1111/imm.12669. CC BY. This page provides an original explanatory appraisal; no source figures are reproduced.